Categories

menu_banner1

-20%
off

News Scan for Mar 31, 2021

Racial disparities in COVID vaccine uptake noted, even in health workers Racial and ethnic differences in intention to receive a COVID-19 vaccine were comparable across both healthcare workers (HCWs) and the general public in the San Francisco Bay area this winter, according to survey results published yesterday in JAMA Internal Medicine. The survey, led by

News Scan for Mar 30, 2021

Study shows deeper COVID impact in socially vulnerable neighborhoods An analysis of neighborhood-level data in three US cities highlights the racial and socioeconomic disparities in COVID-19 positivity, incidence, and mortality, researchers reported today in the Annals of Internal Medicine. For the study, researchers from Drexel University’s Dornsife School of Public Health used data on the

News Scan for Mar 26, 2021

News Scan for Mar 26, 2021

Long-haul COVID-19 likelihood associated with middle age, female sex Researchers reporting on two non-peer–reviewed studies published this week on the preprint server medRxiv followed up months after adults’ COVID-19 hospitalization and found that 55% to 71% have not fully recovered. Middle age and female sex were associated with a higher likelihood of worse recovery in

Stewardship / Resistance Scan for Mar 26, 2021

Stewardship / Resistance Scan for Mar 26, 2021

Report highlights barriers to hospital stewardship in LMICs Interviews with clinicians at hospitals in three low- and middle-income countries highlight some of the barriers to appropriate antibiotic prescribing in these settings, according to a study published yesterday in Antimicrobial Resistance & Infection Control. For the study, an international team led by researchers with Duke Global

Plant-Based Vaccine Manufacturing for Influenza, Implications for Future Vaccines

Currently, the development of vaccines for influenza and other viruses typically relies on egg-based manufacturing. This approach, and the newer technique of vaccine production in cell cultures, carry the risk of mutations that may reduce the efficacy and immunogenicity of the vaccines. Additionally, there are ongoing needs for greater production speed and capacity to enable

Brands:
en_USEnglish